Will Merck's Guidance Cut Prove Gruesome In The Wake Of Januvia, Gardasil Misses?
Sales of Merck's new drug, Winrevair, more than doubled sequentially in the third quarter. The news could bolster downtrodden Merck stock. The post Will Merck's Guidance Cut Prove Gruesome In The Wake Of Januvia, Gardasil Misses? appeared first on Investor's Business Daily.
Sales of Merck's new drug, Winrevair, more than doubled sequentially in the third quarter. The news could bolster downtrodden Merck stock.
The post Will Merck's Guidance Cut Prove Gruesome In The Wake Of Januvia, Gardasil Misses? appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
